Femoral pseudoaneurysm (FPA) is the most common complication associated with percutaneous coronary interventions. The purpose of this study is to identify the risk factors associated with FPA after cardiac catheterization, and the impact of FPA on total hospital cost and duration of stay. The Nationwide/National Inpatient Sample was queried from 2006 to 2014 to identify patients having percutaneous coronary interventions who then developed FPA. The χ2 test, Wilcoxon rank-sum test, Cochran-Armitage trend test, and multivariable logistic regression analysis were used for data analysis and statistics. Total hospital cost adjusted to 2014 dollars, and duration of stay are reported as a median with an interquartile range (IQR). A total of 12,439,109 patients had coronary procedures from 2006 to 2014. Among them, 36,262 (290 per 100,000 cases) developed FPA. The rate has increased from 260 in 100,000 in 2006 to 310 in 100,000 in 2014 (P < .0001 for trend). Patient age is associated with FPA, with patients 75 and older having a significantly greater rate of FPA (0.44%) compared with other age groups: 18-54 (0.18%), 55-64 (0.23%), and 65-74 (0.32%; P < .0001). FPA is twice as prevalent in females vs males (0.40% vs 0.22%; P < .0001). Caucasians and Hispanics were more likely to develop FPA compared with African Americans (odds ratio [OR], 1.66; 95% confidence interval [CI], 1.59-1.83 and OR, 1.64; 95% CI, 1.54-1.74, respectively). As expected, diagnostic procedures had the lowest rate of FPA (0.22%) compared with angioplasty (0.39%) or stent placement (0.33%; P < .0001). Surprisingly, patients with elective admission were 1.22 times as likely to have FPA (95% CI, 1.19-1.25) than those with nonelective hospitalization. Interestingly, patients in urban hospitals had the highest incidence of FPA (0.30% in urban teaching and 0.28% in urban nonteaching vs 0.20% in rural hospitals; P < .0001). Compared with the Northeast region, FPA incidence was greater in the West (OR, 1.12; 95% CI, 1.08-1.16) and highest in the Midwest and South regions (OR, 1.24; 95% CI, 1.20-1.28 for both). FPA resulted in a significant increase in duration of stay, from 3 days (IQR, 1-6 days) to 5 days (IQR, 3-9 days; P < .001), and resulted in a 30% increase in total cost of hospitalization, from $15,651 (IQR, $10,102-$24,967) to $22,347 (IQR, $15,159-$34,030). FPA after coronary procedures is a significant complication, resulting in unacceptable increases in both hospital duration of stay and total cost. With the incidence of FPA increasing, urgent attention and further root cause analysis is indicated to reduce this adverse trend in patient outcomes.
Read full abstract